We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$90.8M +$23.5M +261,373 +44%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$70.6M +$3.09M +34,422 +5%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$50.4M -$1.8M -20,044 -4%
NAMA
4
Nikko Asset Management Americas
New York
$38.9M -$1.9M -21,162 -4%
BlackRock
5
BlackRock
New York
$35.4M +$4.55M +50,695 +18%
FP
6
Flagship Pioneering
Massachusetts
$31.3M
Vanguard Group
7
Vanguard Group
Pennsylvania
$20.3M +$925K +10,300 +6%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$16.4M -$6.65M -74,108 -33%
SB
9
Samsara BioCapital
California
$15.9M -$1.39M -15,470 -9%
State Street
10
State Street
Massachusetts
$9.01M +$1.72M +19,202 +29%
JP Morgan Chase
11
JP Morgan Chase
New York
$8.46M -$792K -8,829 -10%
BBA
12
Baker Bros. Advisors
New York
$7.36M
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$6.01M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$6.01M +$589K +6,561 +13%
PCM
15
Portolan Capital Management
Massachusetts
$5.32M -$125K -1,390 -3%
Northern Trust
16
Northern Trust
Illinois
$5.25M +$760K +8,464 +21%
AG
17
Artal Group
Luxembourg
$5.22M -$145K -1,614 -3%
AVM
18
Arch Venture Management
Illinois
$4.26M -$23.9M -266,382 -87%
SCM
19
Sio Capital Management
New York
$2.91M -$1.76M -19,563 -42%
Charles Schwab
20
Charles Schwab
California
$2.67M +$410K +4,572 +22%
Two Sigma Investments
21
Two Sigma Investments
New York
$2.63M +$2.22M +24,700 New
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$2.48M +$1.32M +14,761 +174%
RG
23
Redmile Group
California
$2.26M
Nuveen
24
Nuveen
North Carolina
$2.17M +$580K +6,466 +47%
Two Sigma Advisers
25
Two Sigma Advisers
New York
$1.94M +$915K +10,190 +127%